NEW YORK ( TheStreet) -- Novo Nordisk A/S (NYSE: NVO) hit a new 52-week high Monday as it is currently trading at $145.24, above its previous 52-week high of $144.92 with 133,299 shares traded as of 10:55 a.m. ET. Average volume has been 268,500 shares over the past 30 days. Novo Nordisk A/S has a market cap of $68.43 billion and is part of the health care sector and drugs industry. Shares are up 20.4% year to date as of the close of trading on Friday. Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products in Denmark and internationally. The company operates in two segments, Diabetes Care and Biopharmaceuticals. The company has a P/E ratio of four, below the average drugs industry P/E ratio of 22.5 and below the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter